Help us build on our understanding of advancing relapsing multiple sclerosis
Join this clinical study to research a medication under investigation for people with advancing relapsing multiple sclerosis
The EXCHANGE Study is for people with relapsing multiple sclerosis (RMS) who are already being treated with a medication for MS called a “disease-modifying therapy (DMT).” The goal of the study is to see whether switching from a DMT to the medication under investigation is safe for people with RMS. If you take part in the study, you will switch from your current DMT to the medication under investigation, which is also a DMT.
Up to 400 patients across the United States will take part. Study-related medical care and the medication under investigation will be provided at no cost, and participants may be eligible to receive financial reimbursement for their time in the study.
You may be eligible to participate in this MS study if you:
- are 18–65 years of age
- have RMS and your symptoms are getting worse over time
- have been continuously treated with an MS medication for at least 3 months
Please contact the study team today if you are interested in joining the EXCHANGE Study or would like more information. By contacting us, you are under no obligation to take part in the study. We look forward to hearing from you soon.